Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02567 | 34326946 | World J Diabetes | Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. | 2021 | Details |
| A02568 | 34326886 | Evid Based Complement Alternat Med | Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Ecliptae herba on Hepatocellular Carcinoma. | 2021 | Details |
| A02569 | 34326816 | Front Endocrinol (Lausanne) | New Mammalian Glycerol-3-Phosphate Phosphatase: Role in β-Cell, Liver and Adipocyte Metabolism. | 2021 | Details |
| A02570 | 34326695 | Int J Biol Sci | Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice. | 2021 | Details |
| A02571 | 34326608 | World J Gastroenterol | Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. | 2021 | Details |
| A02572 | 34326208 | Science | Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion. | 2021 | Details |
| A02573 | 34326098 | BMJ Open Gastroenterol | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. | 2021 | Details |
| A02574 | 34326020 | Surg Obes Relat Dis | Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease. | 2021 | Details |
| A02575 | 34326012 | J Genet Genomics | Fructose and fructose kinase in cancer and other pathologies. | 2021 | Details |
| A02576 | 34325952 | J Formos Med Assoc | The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? | 2021 | Details |
| A02577 | 34325939 | Eur J Surg Oncol | Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC. | 2021 | Details |
| A02579 | 34324263 | Diabetes Obes Metab | Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. | 2021 | Details |
| A02580 | 34324132 | Indian J Pediatr | Usefulness of Controlled Attenuation Parameter for Identification and Grading of Nonalcoholic Fatty Liver Disease in Adolescents with Obesity. | 2021 | Details |
| A02581 | 34323908 | Food Funct | Whole body metabolism is improved by hemin added to high fat diet while counteracted by nitrite: a mouse model of processed meat consumption. | 2021 | Details |
| A02582 | 34323067 | J Agric Food Chem | Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD. | 2021 | Details |
| A02583 | 34322898 | Hepatology | Guanine Nucleotide-Binding Protein G(i) Subunit Alpha 2 Exacerbates NASH Progression by Regulating Peroxiredoxin 1-Related Inflammation and Lipophagy. | 2021 | Details |
| A02584 | 34322514 | Front Nutr | Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. | 2021 | Details |
| A02585 | 34322121 | Front Immunol | CD8+ T Cells Involved in Metabolic Inflammation in Visceral Adipose Tissue and Liver of Transgenic Pigs. | 2021 | Details |
| A02586 | 34321990 | Prz Menopauzalny | Bariatric surgery: blessing or sometimes curse for the liver? | 2021 | Details |
| A02587 | 34321850 | World J Gastroenterol | PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A02588 | 34321846 | World J Gastroenterol | Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. | 2021 | Details |
| A02589 | 34321839 | World J Gastroenterol | Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease. | 2021 | Details |
| A02590 | 34321567 | Sci Rep | High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity. | 2021 | Details |
| A02593 | 34321421 | J Pediatr Gastroenterol Nutr | Unhealthy Eating, Psychopathology, and Nonalcoholic Fatty Liver Disease in Youth Presenting for Bariatric Surgery. | 2021 | Details |
| A02594 | 34321089 | Stem Cell Res Ther | Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells. | 2021 | Details |
| A02595 | 34321005 | Lipids Health Dis | Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. | 2021 | Details |
| A02596 | 34320987 | Cardiovasc Diabetol | A molecular signature for the metabolic syndrome by urine metabolomics. | 2021 | Details |
| A02597 | 34320238 | Hepatology | SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR. | 2021 | Details |
| A02598 | 34320173 | Am J Clin Nutr | The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. | 2021 | Details |
| A02599 | 34319647 | Mol Nutr Food Res | The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population. | 2021 | Details |
| A02600 | 34315516 | Chin Med | Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology. | 2021 | Details |
| A02601 | 34314787 | Adv Drug Deliv Rev | Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. | 2021 | Details |
| A02602 | 34314306 | Immunopharmacol Immunotoxicol | The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions. | 2021 | Details |
| A02603 | 34312684 | J Mol Med (Berl) | Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1. | 2021 | Details |
| A02604 | 34312182 | Diabetes Care | Preparing for the NASH Epidemic: A Call to Action. | 2021 | Details |
| A02605 | 34312112 | Hematol Transfus Cell Ther | Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia. | 2021 | Details |
| A02606 | 34311531 | Biomed Pharmacother | FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway. | 2021 | Details |
| A02607 | 34311134 | Clin Res Hepatol Gastroenterol | Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. | 2021 | Details |
| A02608 | 34311133 | Clin Res Hepatol Gastroenterol | How will NAFLD change the liver transplant landscape in the 2020s? | 2021 | Details |
| A02609 | 34311022 | Diabetes Res Clin Pract | Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial. | 2021 | Details |
| A02610 | 34310978 | Gastroenterology | TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial. | 2021 | Details |
| A02611 | 34310738 | Hepatology | Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. | 2021 | Details |
| A02613 | 34309833 | Eur J Clin Invest | Is there an 'ideal' diet for patients with NAFLD? | 2021 | Details |
| A02614 | 34309471 | Ann Med | Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A02615 | 34308859 | Nan Fang Yi Ke Da Xue Xue Bao | [Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway]. | 2021 | Details |
| A02616 | 34308853 | Nan Fang Yi Ke Da Xue Xue Bao | [Parathyroid hormone-related protein aggravates nonalcoholic fatty liver disease induced by methionine choline-deficient diet in mice]. | 2021 | Details |
| A02617 | 34308754 | Tissue Barriers | Effect of Adipose derived mesenchymal stem cells on multiple Organ Injuries in diet-induced obese mice. | 2021 | Details |
| A02618 | 34308509 | J Egypt Natl Canc Inst | Green tea catechins in combination with irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model. | 2021 | Details |
| A02619 | 34307562 | World J Clin Cases | Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea. | 2021 | Details |
| A02620 | 34307250 | Front Pediatr | Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2021 | Details |
| A02621 | 34306519 | Am J Transl Res | miR-122-5p/KIF5B/AMPK/AKT regulatory network regulates the progression of NAFLD [Retraction]. | 2021 | Details |
| A02622 | 34306045 | PPAR Res | Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02623 | 34305621 | Front Pharmacol | Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway. | 2021 | Details |
| A02624 | 34305351 | J Clin Exp Hepatol | SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? | 2021 | Details |
| A02625 | 34305077 | Exp Anim | AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment. | 2021 | Details |
| A02626 | 34304291 | Abdom Radiol (NY) | Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility. | 2021 | Details |
| A02627 | 34304139 | Biomaterials | A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model. | 2021 | Details |
| A02628 | 34303881 | Cell Mol Gastroenterol Hepatol | White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A02629 | 34303827 | Clin Res Hepatol Gastroenterol | Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02630 | 34303710 | Biochem Pharmacol | Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. | 2021 | Details |
| A02631 | 34302449 | Clin Pharmacol Drug Dev | Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers. | 2021 | Details |
| A02632 | 34302259 | Endocrine | Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study. | 2021 | Details |
| A02633 | 34300354 | J Clin Med | Albuminuria Is Associated with Hepatic Iron Load in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome. | 2021 | Details |
| A02634 | 34300352 | J Clin Med | Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival-A Retrospective Analysis of a Slovak Cohort. | 2021 | Details |
| A02635 | 34300227 | J Clin Med | Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02636 | 34300193 | J Clin Med | Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. | 2021 | Details |
| A02637 | 34300021 | Int J Environ Res Public Health | The Impact of Nordic Walking on Bone Properties in Postmenopausal Women with Pre-Diabetes and Non-Alcohol Fatty Liver Disease. | 2021 | Details |
| A02638 | 34299336 | Int J Mol Sci | Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. | 2021 | Details |
| A02639 | 34299321 | Int J Mol Sci | Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. | 2021 | Details |
| A02640 | 34299189 | Int J Mol Sci | Current Options and Future Directions for NAFLD and NASH Treatment. | 2021 | Details |
| A02641 | 34298998 | Int J Mol Sci | Raman Study on Lipid Droplets in Hepatic Cells Co-Cultured with Fatty Acids. | 2021 | Details |
| A02642 | 34298967 | Int J Mol Sci | Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02643 | 34298930 | Int J Mol Sci | Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts. | 2021 | Details |
| A02644 | 34298870 | Int J Mol Sci | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance. | 2021 | Details |
| A02645 | 34298842 | Cancers (Basel) | Circadian Clock and Liver Cancer. | 2021 | Details |
| A02646 | 34298832 | Cancers (Basel) | An Update on Hepatocellular Carcinoma in Chronic Kidney Disease. | 2021 | Details |
| A02647 | 34298690 | Cancers (Basel) | Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort. | 2021 | Details |
| A02648 | 34298687 | Cancers (Basel) | Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. | 2021 | Details |
| A02649 | 34298442 | Biomaterials | Nanocapsule-mediated sustained H2 release in the gut ameliorates metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02650 | 34297902 | Nucleic Acid Ther | Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02651 | 34297882 | Liver Int | Associations between alcohol consumption and hepatic steatosis in the USA. | 2021 | Details |
| A02652 | 34297733 | PLoS One | Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study. | 2021 | Details |
| A02653 | 34297426 | Hepatology | Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A02654 | 34297346 | Curr Obes Rep | Endoscopic Procedures for Weight Loss. | 2021 | Details |
| A02655 | 34295993 | Clin Exp Hepatol | Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A02656 | 34295987 | Clin Exp Hepatol | Correlation of endoscopic findings with Doppler ultrasound in portal hypertension in children. | 2021 | Details |
| A02657 | 34295984 | Clin Exp Hepatol | Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study. | 2021 | Details |
| A02658 | 34294937 | Pathologica | Pathology of non-alcoholic fatty liver disease. | 2021 | Details |
| A02659 | 34294714 | Nat Commun | CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. | 2021 | Details |
| A02660 | 34294656 | J Clin Gastroenterol | Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. | 2021 | Details |
| A02661 | 34294580 | Dig Liver Dis | Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2021 | Details |
| A02662 | 34294375 | J Pharmacol Sci | Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. | 2021 | Details |
| A02663 | 34293421 | Ann Epidemiol | Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA). | 2021 | Details |
| A02664 | 34293354 | J Invest Dermatol | Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies. | 2021 | Details |
| A02665 | 34292604 | Hepatology | Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. | 2021 | Details |
| A02666 | 34292372 | J Gastroenterol | HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation. | 2021 | Details |
| A02667 | 34292171 | Eur J Endocrinol | A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies. | 2021 | Details |
| A02668 | 34291454 | Eur J Clin Invest | Omega-3 phospholipids and obesity-associated NAFLD: Potential mechanisms and therapeutic perspectives. | 2021 | Details |
| A02669 | 34290609 | Front Pharmacol | Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis. | 2021 | Details |
| A02670 | 34290320 | Sci Rep | AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. | 2021 | Details |